Clinical trials Phase CTL Approve Hospital
Pt.no
Remark
Prophylaxis of EBV/CMV infection after Allogeneic Hemopoietic Stem Cell Transplantation by EBV/CMV Specific Cytotoxic T Lymphocytes I/II hCMV/EBV-specific CTL 2004 St.Mary’s hospital/2 complete
Prophylaxis of CMV infection after Allogeneic Hemopoietic Stem Cell Transplantation by CMV Specific Cytotoxic T Lymphocytes I/II hCMV-specific CTL 2005 St.Mary’s hospital/1 complete
Therapy of sustained remission of refractory AML pt. by WT1 Specific Cytotoxic T Lymphocytes I/II WT1-specific CTL 2005 St.Mary’s hospital/1 complete
For the treatment of hepatocellular carcinoma (HCC) Alpha-fetoprotein (AFP) specific CTLs therapy Recurrence after liver transplantation I/II AFP-specific CTL 2006 Kangnam St.Mary’s hospital/1 complete
Adoptive immunotherapy using WT1 specific CTLs for high-risk adult acute myeloid leukemia patient I/II WT1-specific CTL 2007 Seoul St.Mary’s hospital/10 complete
Adoptive Immunotherapy using Epstein-Barr Virus-Specific Cytotoxic T-Lymphocytes for Patients with EBV-Associated Extranodal NK/T cell Lymphoma I/II EBV-specific CTL 2007 Seoul St.Mary’s hospital/11 complete